Andrew Daugulis is a Professor and holds the Queen's University Research Chair in Biochemical and Cell Culture Engineering, and is an expert in industrial bioprocessing applied to the production of biofuels and high value chemical intermediates.  He originated, and has licensed, the Two-Phase Partitioning Bioreactor (TPPB) technology platform which allows the selective partitioning of target toxic molecules to, or away from, microbial cells – maintaining inhibitory molecules at sub-toxic levels, and allowing microbes to operate at their highest efficiency.  Daugulis continues to define, and successfully demonstrate new opportunities for TPPB applications, including advances in the development of "green" solvent-free industrial bioprocessing.